| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 554.52 Million |
| Market Size (2030) | USD 920.17 Million |
| CAGR (2025 - 2030) | 10.66 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
France Aesthetic Medicine Market Analysis
The France Aesthetic Medicine Market size is estimated at USD 554.52 million in 2025, and is expected to reach USD 920.17 million by 2030, at a CAGR of 10.66% during the forecast period (2025-2030).
- The aesthetic medicine market in France is expected to grow during the forecast period owing to increasing awareness about cosmetic procedures and the adoption of non- and minimally-invasive aesthetic procedures.
- For instance, according to Le Monde, in October 2022, stated that the International Master Course on Aging Science (IMCAS) marked the of post-Covid demand, the latest advances in "aging sciences," the future innovative products and techniques such as botulinum super-toxin for longer-lasting brows, synthetic hair implants to overcome baldness, ultrasound or electromagnetic wave devices for a more toned body and firmer skin, and temporary aesthetic medicine solutions such as tissue regeneration using the multipotent stem cells.
- For instance, an article published by the European Society of Medicine in September 2022 stated that aesthetic medicine is being increasingly portrayed in the context of public health. Public behavioral trends and specialized developments in the healthcare sector have transformed public health awareness. Aesthetic medicine is a tool that helps people improve not only their physical but also their emotional state. Thus, an increase in cosmetic procedures in France is expected to drive the market in the forecast period.
- However, stringent safety regulations for aesthetic procedures and related adverse effects are expected to restrain France's aesthetic medicine market growth during the forecast period.
France Aesthetic Medicine Market Trends
Dermal Filler is Expected to Have a Significant Share in the Market Over the Forecast Period
- Dermal fillers are medical device implants used to help create a smoother and/or fuller appearance in the face, including nasolabial folds (the lines extending from the sides of the nose to the edges of the mouth), cheeks, chin, lips, and back of the hands. They are also referred to as injectable implants, soft tissue fillers, lipand facial fillers, and wrinkle fillers.
- Hence, owing to their diverse use in the aesthetics industry, dermal fillers are expected to have a significant share in the French aesthetic medicine market during the forecast period. Numerous surgical and non-surgical reconstructive methods are available to improve oral function, anatomical structures, and aesthetic results to appear more attractive. Dermal fillers are the most used non-surgical procedure to improve the aesthetics and anatomy of the face. The key players are developing innovative solutions in derma fillers to increase demand for non-surgical derma fillers.
- For instance, in December 2023, Evolus, Inc., a performance beauty company with a focus on building an aesthetic portfolio, announced that it has entered into a definitive agreement with Symatese to be the exclusive distributor in the United Kingdom and Europe of four unique dermal fillers in late-stage development with anticipated regulatory clearances in second half of 2024 and commercialization under the brand name Estyme fillers in 2025.
- In addition, the technological advancements in the area and the launch of new products by the companies operating in the region are further expected to boost market growth. For instance, in November 2023, Innerskin aesthetic clinic in France has raised 5 million euros (USD 5.56 Million) to improve the aesthetic medical service and products in France.
- All the above mentioned factors are responsible for the healthy growth over the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
Hospitals is Expected to Have a Significant Share in the Market Over the Forecast Period
- The operating unit of the hospital is considered one of the safest and most high-tech surgical units because of the advanced equipment available in the hospitals. The rise in plastic surgeries in France in hospitals and the increase in healthcare expenditure are expected to drive the market's growth.
- For instance, according to data from the Plastic Surgery Societies' Surveys (ISAPS) updated in 2023, the most popular cosmetic surgeries in France in 2023 were Breast Augmentation (43,800 treatments), Liposuction (35,500 procedures), Eyelid Surgery (35,900 procedures), Abdominoplasty (24,200 procedures), and Breast Reduction (25,100 procedures). Thus, the increasing number of plastic surgeries is most likely to drive aesthetic medicine in the country.
- Furthermore, according to the Organization for Economic Co-operation and Development (OECD), healthcare expenditure in France was around USD 6630 per capita in 2023 more than the OECD average of $4986 (USD PPP). Thus, the increasing healthcare expenditure will likely positively impact the market over the forecast period.
Get Analysis on Important Geographic Markets
Download PDF
France Aesthetic Medicine Industry Overview
The France aesthetic medicine market is moderatly competitive due to the presence of companies operating globally as well as regionally.
The competitive landscape includes an analysis of a few international as well as local companies which hold significant market shares and are well known including AbbVie Inc. (Allergan Plc), Bioxis Pharmaceuticals, Dermaceutic Laboratoire, Ipsen Pharma, Sinclair Pharma PLC, and Galderma(Nestle Skin Health), among others.
France Aesthetic Medicine Market Leaders
-
AbbVie Inc. (AlLergan Plc)
-
Bioxis Pharmaceuticals
-
Dermaceutic Laboratoire
-
Ipsen Pharma
-
Sinclair Pharma PLC
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
France Aesthetic Medicine Market News
- May 2024: AstraZeneca, Sanofi, Pfizer invested around €1.87 Bn (USD 2.1 Bn) in the France market to enhance their operations in France.
- November 2023: Genese Labs France introduced the RG60 Body Filler, an injectable formulated with a potent 24mg/ml cross-linked hyaluronic acid concentration, promising to redefine non-surgical body contouring practices.
- January 2022: the European Union's (EU's) Heads of Medicines Agencies (HMA) issued a positive opinion on the approval of Hugel's Letybo, a product containing botulinum toxin (BTX) for the treatment of wrinkles on the forehead.
France Aesthetic Medicine Industry Segmentation
Aesthetic medicine is defined as the specialties that focus on enhancing cosmetic appearance through the treatment of aging, infectious, or diseased skin conditions.
The France aesthetic medicine market is segmented by product and end-user. The product segment of the market is further segmented into botulinum toxin, dermal filler, chemical peel, microdermabrasion, and other products. The dermal filler sub-segmnet is further bifurcated into absorbable dermal filler and non-absorbable dermal filler. The end-user segment of the market is further segmented into aesthetic clinics, hospitals, and other end users. The market report also covers the estimated market sizes and trends for France. The report offers the value (in USD) for the above segments.
| By Product | Botulinum Toxin | ||
| Dermal Filler | Absorbable Dermal Filler | ||
| Non-absorbable Dermal Filler | |||
| Chemical Peel | |||
| Microdermabrasion | |||
| Other Products | |||
| By End User | Aesthetic Clinics | ||
| Hospitals | |||
| Other End Users | |||
Need A Different Region or Segment?
Customize Now
France Aesthetic Medicine Market Research Faqs
How big is the France Aesthetic Medicine Market?
The France Aesthetic Medicine Market size is expected to reach USD 554.52 million in 2025 and grow at a CAGR of 10.66% to reach USD 920.17 million by 2030.
What is the current France Aesthetic Medicine Market size?
In 2025, the France Aesthetic Medicine Market size is expected to reach USD 554.52 million.
Who are the key players in France Aesthetic Medicine Market?
AbbVie Inc. (AlLergan Plc), Bioxis Pharmaceuticals, Dermaceutic Laboratoire, Ipsen Pharma and Sinclair Pharma PLC are the major companies operating in the France Aesthetic Medicine Market.
What years does this France Aesthetic Medicine Market cover, and what was the market size in 2024?
In 2024, the France Aesthetic Medicine Market size was estimated at USD 495.41 million. The report covers the France Aesthetic Medicine Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the France Aesthetic Medicine Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
France Aesthetic Medicine Industry Report
Statistics for the 2025 France Aesthetic Medicine market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. France Aesthetic Medicine analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
